Duan Yongping’s Moderna MRNA Stock Holding History

Duan Yongping’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83,000	Closed	-$2.35M	–	11
2025 Q1	$2.35M	Sell	83,000 -80,000	-49%	-$2.84M	0.02%	11
2024 Q4	$6.78M	Buy	163,000 +65,300	+67%	+$3.12M	0.05%	8
2024 Q3	$6.53M	Sell	97,700 -43,000	-31%	-$3.95M	0.04%	8
2024 Q2	$16.7M	Hold	140,700	–	–	0.1%	7
2024 Q1	$15M	Buy	140,700 +200	+0.1%	+$20.2K	0.11%	7
2023 Q4	$14M	Buy	140,500 +36,500	+35%	+$3.07M	0.1%	7
2023 Q3	$10.7M	Sell	104,000 -36,000	-26%	-$4.02M	0.08%	8
2023 Q2	$17M	Sell	140,000 -10,000	-7%	-$1.33M	0.12%	6
2023 Q1	$23M	Sell	150,000 -10,000	-6%	-$1.65M	0.17%	7
2022 Q4	$28.7M	Hold	160,000	–	–	0.27%	6
2022 Q3	$18.9M	Hold	160,000	–	–	0.2%	6
2022 Q2	$22.9M	Hold	160,000	–	–	0.27%	6
2022 Q1	$27.6M	Buy	160,000 +100,000	+167%	+$16.8M	0.29%	6
2021 Q4	$15.2M	Buy	+60,000	New	+$17.5M	0.19%	9

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Duan Yongping's MRNA Position: Q2 2025 in Review

Duan Yongping sold out of Moderna (MRNA) in Q2 2025, closing a stake of 83,000 shares — an estimated $2.35M sold.

Duan Yongping first reported a position in MRNA in Q4 2021 and held it in 14 quarters. The position peaked at $28.7M in Q4 2022. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

Duan Yongping reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
Duan Yongping sold 83,000 Moderna shares in Q2 2025, an estimated $2.35M.
Duan Yongping first reported a position in Moderna in Q4 2021 and held it in 14 quarters.
Duan Yongping's Moderna position peaked at $28.7M in Q4 2022.
675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on H&H International Investment's 13F filing for Q2 2025, filed 14 Aug 2025.